Skip to main content

Table 2 Median scores of the 23 trials for each domain of the PRECIS-2 tool

From: How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool

Title of domain

Median score

Number of articles with missing data

Articles for which scoring required a consensus

Articles for which scoring required a consensus between a score rather explanatory (<3) or pragmatic (>3)

(Q1; Q3)

N (%)

N (%a)

N (%a)

Eligibility

2 (1; 2))

1/23 (4)

14/22 (64)

1/22 (5)

Recruitment

1 (1; 3)

10/23 (43)

10/13 (77)

5/13 (38)

Setting

2 (1; 2)

3/23 (13)

17/20 (85)

4/20 (20)

Organisation

2 (1; 2)

3/23 (13)

16/20 (80)

1/20 (5)

Flexibility of delivery

2 (2; 4)

6/23 (26)

13/17 (76)

1/17 (6)

Flexibility of adherence

2 (1.75; 2)

9/23 (39)

10/14 (71)

3/14 (21)

Follow up

2 (2; 3)

4/23 (17)

16/19 (84)

1/19 (5)

Primary outcome

2 (1; 3.25)

3/23 (13)

12/20 (60)

5/20 (25)

Primary analysis

4 (1; 5)

6/23 (26)

12/17 (71)

0/17 (0)

  1. aThe consensus was any discrepancy in the scores between the two researchers (ET and CD-D)